Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Robert M. Anglin currently holds 21,157 shares of ROCHESTER MEDICAL CORPORATION (ROCM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert M. Anglin has been a net seller of ROCM stock. They have purchased $0 and sold $129.7K worth of shares.
Robert M. Anglin's most recent insider trade was on Nov 14, 2013, when they sold 21,157 shares at $20.00 per share.
Robert M. Anglin serves as Executive at ROCHESTER MEDICAL CORPORATION (ROCM). They have executed 8 insider transactions totaling $129.7K over their tenure at the company.
Robert M. Anglin holds the position of Executive at ROCHESTER MEDICAL CORPORATION, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 16 years and currently hold a stake valued at $0.
Robert M. Anglin has shown a selling trading pattern, with $0 in total purchases and $129.7K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Robert M. Anglin was on Nov 14, 2013, when they sold $423.1K worth of ROCM shares. This transaction involved 21,157 shares at $20.00 per share.
Robert M. Anglin currently owns 21,157 shares of ROCHESTER MEDICAL CORPORATION (ROCM), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Robert M. Anglin's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Robert M. Anglin has 8 Form 4 filings on record as an insider at ROCHESTER MEDICAL CORPORATION.
Set alerts for Robert M. Anglin and 40,000+ other insiders.